CS331091A3 - Synergistic combination of compounds inhibiting hiv-reverse transcriptase and a pharmaceutical based thereon - Google Patents

Synergistic combination of compounds inhibiting hiv-reverse transcriptase and a pharmaceutical based thereon Download PDF

Info

Publication number
CS331091A3
CS331091A3 CS913310A CS331091A CS331091A3 CS 331091 A3 CS331091 A3 CS 331091A3 CS 913310 A CS913310 A CS 913310A CS 331091 A CS331091 A CS 331091A CS 331091 A3 CS331091 A3 CS 331091A3
Authority
CS
Czechoslovakia
Prior art keywords
methyl
ethyl
pyridinone
amino
compound
Prior art date
Application number
CS913310A
Other languages
Czech (cs)
English (en)
Inventor
Paul A Friedman
Emilio A Emini
Jack Nunberg
Julio C Quintero
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CS331091A3 publication Critical patent/CS331091A3/cs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS913310A 1990-11-01 1991-10-31 Synergistic combination of compounds inhibiting hiv-reverse transcriptase and a pharmaceutical based thereon CS331091A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60810490A 1990-11-01 1990-11-01
US64585791A 1991-01-25 1991-01-25

Publications (1)

Publication Number Publication Date
CS331091A3 true CS331091A3 (en) 1992-05-13

Family

ID=27085675

Family Applications (1)

Application Number Title Priority Date Filing Date
CS913310A CS331091A3 (en) 1990-11-01 1991-10-31 Synergistic combination of compounds inhibiting hiv-reverse transcriptase and a pharmaceutical based thereon

Country Status (15)

Country Link
EP (1) EP0484071A3 (es)
JP (1) JPH04300834A (es)
KR (1) KR920009394A (es)
CN (1) CN1062138A (es)
AU (1) AU648121B2 (es)
CA (1) CA2054529A1 (es)
CS (1) CS331091A3 (es)
FI (1) FI915152A (es)
HU (1) HUT60135A (es)
IE (1) IE913751A1 (es)
IL (1) IL99843A0 (es)
MX (1) MX9101880A (es)
NZ (1) NZ240407A (es)
PT (1) PT99394A (es)
YU (1) YU172991A (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177435B1 (en) 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
GB9215176D0 (en) * 1992-07-16 1992-08-26 Glaxo Group Ltd Antiviral combinations
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
WO1994018963A1 (en) * 1993-02-22 1994-09-01 Janssen Pharmaceutica N.V. Method of reversing resistance of hiv-1 strains to zidovudine
US5968910A (en) * 1994-11-30 1999-10-19 Jan M. R. Balzarini Compositions containing two or three inhibitors of different HIV reverse transcriptases
EP0906756A4 (en) * 1996-04-04 2000-11-22 Shionogi & Co ANTI-HIV COMPOSITION CONTAINING IMIDAZOLE DERIVATIVE
US6469006B1 (en) * 1999-06-15 2002-10-22 Bristol-Myers Squibb Company Antiviral indoleoxoacetyl piperazine derivatives
NL1012825C2 (nl) * 1999-08-13 2001-02-23 Faculteit Geneeskunde Universi Farmaceuticum voor de behandeling van virale infecties in het bijzonder van het humane immunodeficiency virus (HIV).
US6476034B2 (en) 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US6573262B2 (en) 2000-07-10 2003-06-03 Bristol-Myers Sqibb Company Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
US20030207910A1 (en) 2001-02-02 2003-11-06 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20060100432A1 (en) 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7851476B2 (en) 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
GB0720503D0 (en) 2007-10-22 2007-11-28 Angeletti P Ist Richerche Bio New compound
WO2012019003A1 (en) 2010-08-06 2012-02-09 Bristol-Myers Squibb Company Substituted indole and azaindole oxoacetyl piperazinamide derivatives
ES2585396T3 (es) 2010-12-02 2016-10-05 VIIV Healthcare UK (No.5) Limited Alquilamidas como inhibidores de la unión del VIH
ES2636312T3 (es) 2011-04-12 2017-10-05 VIIV Healthcare UK (No.5) Limited Derivados de tioamida, amidoxima y amidrazona como inhibidores de la fijación del VIH
ES2616268T3 (es) 2011-08-29 2017-06-12 VIIV Healthcare UK (No.5) Limited Derivados condensados de diamina bicíclica como inhibidores de la unión de VIH
EP2751118B1 (en) 2011-08-29 2016-10-12 Bristol-Myers Squibb Company Spiro bicyclic diamine derivatives as hiv attachment inhibitors
US9193725B2 (en) 2012-03-14 2015-11-24 Bristol-Meyers Squibb Company Cyclic hydrazine derivatives as HIV attachment inhibitors
CN108299428B (zh) * 2018-04-04 2019-09-27 山东大学 8-胺基-7-甲酸甲酯-吡嗪骈吡啶酮衍生物及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98526A0 (en) * 1990-06-18 1992-07-15 Merck & Co Inc Pyridones,processes for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU648121B2 (en) 1994-04-14
CA2054529A1 (en) 1992-05-02
PT99394A (pt) 1992-09-30
FI915152A (fi) 1992-05-02
AU8693491A (en) 1992-05-07
EP0484071A3 (en) 1992-11-25
HU913435D0 (en) 1992-01-28
NZ240407A (en) 1994-09-27
YU172991A (sh) 1994-06-24
IL99843A0 (en) 1992-08-18
JPH04300834A (ja) 1992-10-23
IE913751A1 (en) 1992-05-22
CN1062138A (zh) 1992-06-24
KR920009394A (ko) 1992-06-25
FI915152A0 (fi) 1991-10-31
MX9101880A (es) 1992-07-08
HUT60135A (en) 1992-08-28
EP0484071A2 (en) 1992-05-06

Similar Documents

Publication Publication Date Title
CS331091A3 (en) Synergistic combination of compounds inhibiting hiv-reverse transcriptase and a pharmaceutical based thereon
US5583131A (en) Aromatic-linked polyamine macrocyclic compounds with anti-HIV activity
EP3409276B1 (en) Ire-1a inhibitors
US5308854A (en) Inhibitors of HIV reverse transcriptase
CZ280532B6 (cs) Pyridinové a pyridin-N-oxidové deriváty diaryl-methyl-piperidinů nebo piperazinů, jejich použití a způsob jejich přípravy, farmaceutický prostředek je obsahující
AU2017258909A1 (en) Pyrazol-1-yl benzene sulfonamides as CCR9 antagonists
JPS61152655A (ja) ピペラジン誘導体、その製造方法及び該ピペラジン誘導体を有効成分とする新規向精神医薬組成物
CA2888480A1 (en) Heteroaryl linked quinolinyl modulators of ror.gamma.t
CZ400892A3 (en) 2-(4-hydroxypiperidino)-1-alkanol derivatives as anti-ischemic agents, process of their preparation and use
JP5404607B2 (ja) 抗rnaウイルス作用を有するアニリン誘導体
EA008446B1 (ru) Соединения имидазопиридина, способ их получения и фармацевтические композиции, которые их содержат
JP2002519413A (ja) ヒト免疫不全ウイルスの複製を阻害するピペラジン誘導体
WO2014012467A1 (zh) 间二芳基苯胺类或吡啶胺类化合物、其制备方法及医药用途
JP2000508299A (ja) 抗ウイルス作用を有する置換キノリン誘導体
EP0843663B9 (fr) 4-aryl-thio-pyridin-2(1h)-ones, medicaments les contenant et leurs utilisations dans le traitement de maladies liees aux vih
JPH0375542B2 (es)
NO327549B1 (no) Benzo[G]kinolinderivater for behandling av glaukom og myopi
Irikura et al. New antiulcer agents. 1. Synthesis and biological activities of 1-acyl-2-,-3-, and-4-substituted benzamidopiperidines
JPH0377191B2 (es)
Rostom et al. Synthesis and in vitro anti-HIV screening of certain 2-(benzoxazol-2-ylamino)-3H-4-oxopyrimidines
EP0462808A2 (en) Inhibitors of HIV reverse transcriptase
KR100824831B1 (ko) 다치환된 1,1-피리딜아미노시클로프로판아민 화합물, 이의제조 방법, 및 이를 함유하는 약제 조성물
JPH06234753A (ja) イソオキサゾール化合物およびその塩
JP3709203B2 (ja) 5−ht1aレセプターに対して親和性をもつ三環式化合物
CA2566426A1 (en) Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders